123 related articles for article (PubMed ID: 32801034)
21. Propofol facilitates migration and invasion of oral squamous cell carcinoma cells by upregulating SNAI1 expression.
Li C; Xia M; Wang H; Li W; Peng J; Jiang H
Life Sci; 2020 Jan; 241():117143. PubMed ID: 31811855
[TBL] [Abstract][Full Text] [Related]
22. Antiproliferative effects of β-blockers on human colorectal cancer cells.
Coelho M; Moz M; Correia G; Teixeira A; Medeiros R; Ribeiro L
Oncol Rep; 2015 May; 33(5):2513-20. PubMed ID: 25812650
[TBL] [Abstract][Full Text] [Related]
23. Gallic acid inhibits migration and invasion of SCC-4 human oral cancer cells through actions of NF-κB, Ras and matrix metalloproteinase-2 and -9.
Kuo CL; Lai KC; Ma YS; Weng SW; Lin JP; Chung JG
Oncol Rep; 2014 Jul; 32(1):355-61. PubMed ID: 24859325
[TBL] [Abstract][Full Text] [Related]
24. Casticin inhibits invasion and proliferation via downregulation of β-catenin and reversion of EMT in oral squamous cell carcinoma.
Xie Y; Zhong L; Duan D; Li T
J Oral Pathol Med; 2019 Nov; 48(10):897-905. PubMed ID: 31318467
[TBL] [Abstract][Full Text] [Related]
25. Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells.
Carpéné C; Galitzky J; Fontana E; Atgié C; Lafontan M; Berlan M
Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):310-21. PubMed ID: 10344530
[TBL] [Abstract][Full Text] [Related]
26. Beta-adrenergic antagonist propranolol inhibits mammalian cell lysosome spreading and invasion by Trypanosoma cruzi metacyclic forms.
Macedo S; Rodrigues JPF; Schenkman S; Yoshida N
Microbes Infect; 2017; 19(4-5):295-301. PubMed ID: 28111357
[TBL] [Abstract][Full Text] [Related]
27. beta2-adrenergic receptor-selective agonist clenbuterol prevents Fas-induced liver apoptosis and death in mice.
André C; Couton D; Gaston J; Erraji L; Renia L; Varlet P; Briand P; Guillet JG
Am J Physiol; 1999 Mar; 276(3):G647-54. PubMed ID: 10070041
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-340 inhibits squamous cell carcinoma cell proliferation, migration and invasion by downregulating RhoA.
Wang H; Guo W; Jian Q; Xue K; Huang M; Chi S; Li C; Li C
J Dermatol Sci; 2018 Nov; 92(2):197-206. PubMed ID: 30262127
[TBL] [Abstract][Full Text] [Related]
29. Anti-invasion and anti-tumor growth effect of doxycycline treatment for human oral squamous-cell carcinoma--in vitro and in vivo studies.
Shen LC; Chen YK; Lin LM; Shaw SY
Oral Oncol; 2010 Mar; 46(3):178-84. PubMed ID: 20036604
[TBL] [Abstract][Full Text] [Related]
30. Resveratrol suppresses TPA-induced matrix metalloproteinase-9 expression through the inhibition of MAPK pathways in oral cancer cells.
Lin FY; Hsieh YH; Yang SF; Chen CT; Tang CH; Chou MY; Chuang YT; Lin CW; Chen MK
J Oral Pathol Med; 2015 Oct; 44(9):699-706. PubMed ID: 25401496
[TBL] [Abstract][Full Text] [Related]
31. The β-adrenergic receptor antagonist propranolol offsets resistance mechanisms to chemotherapeutics in diverse sarcoma subtypes: a pilot study.
Porcelli L; Garofoli M; Di Fonte R; Fucci L; Volpicella M; Strippoli S; Guida M; Azzariti A
Sci Rep; 2020 Jun; 10(1):10465. PubMed ID: 32591592
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of β2-adrenergic receptor reduces triple-negative breast cancer brain metastases: The potential benefit of perioperative β-blockade.
Choy C; Raytis JL; Smith DD; Duenas M; Neman J; Jandial R; Lew MW
Oncol Rep; 2016 Jun; 35(6):3135-42. PubMed ID: 27035124
[TBL] [Abstract][Full Text] [Related]
33. Protease-activated receptor 2 modulates proliferation and invasion of oral squamous cell carcinoma cells.
Al-Eryani K; Cheng J; Abé T; Maruyama S; Yamazaki M; Babkair H; Essa A; Saku T
Hum Pathol; 2015 Jul; 46(7):991-9. PubMed ID: 25912757
[TBL] [Abstract][Full Text] [Related]
34. Role of HGF/c-met system in invasion and metastasis of oral squamous cell carcinoma cells in vitro and its clinical significance.
Uchida D; Kawamata H; Omotehara F; Nakashiro Ki ; Kimura-Yanagawa T; Hino S; Begum NM; Hoque MO; Yoshida H; Sato M; Fujimori T
Int J Cancer; 2001 Aug; 93(4):489-96. PubMed ID: 11477552
[TBL] [Abstract][Full Text] [Related]
35. Expression of integrin beta 6 enhances invasive behavior in oral squamous cell carcinoma.
Ramos DM; But M; Regezi J; Schmidt BL; Atakilit A; Dang D; Ellis D; Jordan R; Li X
Matrix Biol; 2002 Apr; 21(3):297-307. PubMed ID: 12009335
[TBL] [Abstract][Full Text] [Related]
36. Blockade of β-Adrenergic Receptors Improves CD8
Daher C; Vimeux L; Stoeva R; Peranzoni E; Bismuth G; Wieduwild E; Lucas B; Donnadieu E; Bercovici N; Trautmann A; Feuillet V
Cancer Immunol Res; 2019 Nov; 7(11):1849-1863. PubMed ID: 31527069
[TBL] [Abstract][Full Text] [Related]
37. Expression of KITENIN and its association with tumor progression in oral squamous cell carcinoma.
Yoon TM; Kim SA; Lee JK; Park YL; Kim GY; Joo YE; Lee JH; Kim KK; Lim SC
Auris Nasus Larynx; 2013 Apr; 40(2):222-6. PubMed ID: 22840317
[TBL] [Abstract][Full Text] [Related]
38. A lymph node metastatic mouse model reveals alterations of metastasis-related gene expression in metastatic human oral carcinoma sublines selected from a poorly metastatic parental cell line.
Zhang X; Liu Y; Gilcrease MZ; Yuan XH; Clayman GL; Adler-Storthz K; Chen Z
Cancer; 2002 Oct; 95(8):1663-72. PubMed ID: 12365014
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of metabotropic glutamate receptor 5 expression in oral squamous cell carcinoma.
Park SY; Lee SA; Han IH; Yoo BC; Lee SH; Park JY; Cha IH; Kim J; Choi SW
Oncol Rep; 2007 Jan; 17(1):81-7. PubMed ID: 17143482
[TBL] [Abstract][Full Text] [Related]
40. Antimetastatic potentials of salvianolic acid A on oral squamous cell carcinoma by targeting MMP-2 and the c-Raf/MEK/ERK pathway.
Fang CY; Wu CZ; Chen PN; Chang YC; Chuang CY; Lai CT; Yang SF; Tsai LL
Environ Toxicol; 2018 May; 33(5):545-554. PubMed ID: 29385302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
